Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling with PRP is a safe and effective way to treat chronic alopecia areata, improving hair regrowth with minimal side effects.

Venusia CeraPlus cream and lotion effectively reduce eczema severity and improve skin moisture.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The 60-second timed hair count is a reliable and simple way to measure hair shedding at home, showing older women tend to shed more hair than younger women.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

People with alopecia areata often have lower vitamin D levels than healthy people.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Females with pattern hair loss have more occipital involvement than males.

Oral Apremilast effectively treats alopecia areata in most patients.

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Lulican™ shampoo is more effective and better tolerated than Ketoconazole for treating scalp seborrheic dermatitis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Baricitinib is effective and safe for treating severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.